The Pristine Post-Market Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey Hoggard, MD
Raleigh Access Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Trinity Research Group Llc
Dothan, Alabama, United States
- Yale University
New Haven, Connecticut, United States
- Louisiana State University Health Shreveport Medical Center
Shreveport, Louisiana, United States
- Henry Ford Health System
Detroit, Michigan, United States
- North Carolina Nephrology, Pa
Raleigh, North Carolina, United States
- Jml Research Associates
Providence, Rhode Island, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 May 2022
- Primary completion
- 21 Sept 2022
- Completion
- 21 Sept 2022
- Last update posted
- 11 Apr 2024
- Registered enrollment
- 142
- Registry id
- NCT05228132
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.